WELLS FARGO & COMPANY/MN - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$74,871
-49.8%
871
-45.5%
0.00%
Q2 2023$149,055
+87.9%
1,599
+91.3%
0.00%
Q1 2023$79,308
+350.8%
836
+377.7%
0.00%
Q4 2022$17,593
-12.0%
175
-24.9%
0.00%
Q3 2022$20,000
-13.0%
233
-12.7%
0.00%
Q2 2022$23,000
-95.0%
267
-94.8%
0.00%
Q1 2022$461,000
-59.4%
5,137
-54.7%
0.00%
Q4 2021$1,135,000
+3.3%
11,341
-4.2%
0.00%
Q3 2021$1,099,000
+130.9%
11,840
+111.8%
0.00%
Q2 2021$476,000
-59.7%
5,590
-59.0%
0.00%
Q1 2021$1,181,000
+36.5%
13,646
+32.9%
0.00%
Q4 2020$865,000
-3.1%
10,265
-8.2%
0.00%
Q3 2020$893,000
+5.7%
11,179
+17.1%
0.00%
Q2 2020$845,000
-4.6%
9,544
+1.2%
0.00%
Q1 2020$886,000
+22.2%
9,428
+40.2%
0.00%
Q4 2019$725,000
+11.2%
6,723
-1.1%
0.00%
Q3 2019$652,000
+8.7%
6,800
+8.4%
0.00%
Q2 2019$600,000
-64.2%
6,275
-67.0%
0.00%
Q1 2019$1,676,000
-9.5%
18,993
-14.8%
0.00%
-100.0%
Q4 2018$1,852,000
-7.6%
22,295
+4.7%
0.00%0.0%
Q3 2018$2,005,000
-17.7%
21,289
-3.7%
0.00%0.0%
Q2 2018$2,435,000
+10.5%
22,109
-0.8%
0.00%0.0%
Q1 2018$2,204,000
-4.9%
22,286
-21.7%
0.00%0.0%
Q4 2017$2,317,000
+15.6%
28,464
+4.4%
0.00%0.0%
Q3 2017$2,004,000
+35.5%
27,254
+33.4%
0.00%
Q2 2017$1,479,000
+15.1%
20,433
-1.0%
0.00%
Q1 2017$1,285,000
-14.4%
20,633
+0.0%
0.00%
-100.0%
Q4 2016$1,501,000
+1028.6%
20,632
+827.7%
0.00%
Q3 2016$133,000
-12.5%
2,224
-8.1%
0.00%
Q2 2016$152,000
-12.6%
2,420
-13.0%
0.00%
Q1 2016$174,000
+19.2%
2,783
+11.8%
0.00%
Q4 2015$146,000
+170.4%
2,489
+145.2%
0.00%
Q3 2015$54,000
-23.9%
1,015
-14.6%
0.00%
Q2 2015$71,000
-26.0%
1,188
-25.5%
0.00%
Q1 2015$96,000
+108.7%
1,594
+105.9%
0.00%
Q4 2014$46,000
+24.3%
774
+0.1%
0.00%
Q3 2014$37,000
-17.8%
773
-10.9%
0.00%
Q2 2014$45,000
-59.1%
868
-54.3%
0.00%
Q1 2014$110,000
-16.0%
1,900
-17.4%
0.00%
Q4 2013$131,000
-37.0%
2,300
-34.3%
0.00%
Q3 2013$208,000
+9.5%
3,5000.0%0.00%
Q2 2013$190,0003,5000.00%
Other shareholders
UTAH MED PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Clean Yield Group 49,094$3,535,0001.48%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 27,464$1,988,0000.72%
Ativo Capital Management LLC 16,525$1,196,0000.33%
Ancora Advisors LLC 55,159$3,993,0000.26%
ISTHMUS PARTNERS, LLC 10,754$779,0000.23%
Cardinal Capital Management 9,180$665,0000.22%
Acrospire Investment Management LLC 1,919$139,0000.13%
Penobscot Investment Management Company, Inc. 4,000$290,0000.09%
TFS CAPITAL LLC 3,226$234,0000.09%
WCM INVESTMENT MANAGEMENT, LLC 81,912$5,930,0000.09%
View complete list of UTAH MED PRODS INC shareholders